Edited by Paolo Antonio Ascierto, MD and Jason D. Goldman, MD, MPH
COVID-19 has had a profound impact on the world, and the immunotherapy field can offer important insights into clinical practice, immune-related pathophysiology, and other areas that have proven useful to the global healthcare community. Authored by leading voices in the immuno-oncology, infectious disease, and virology fields, reviews in this series will explore basic insights into the immunology of the novel coronavirus, repurposing of immune-based therapies including the effects of immune-oncology agents, and the affected cancer populations.This series provides a valuable resource to readers, not only as a source for hypothesis-generation for future basic and translational studies, but also as initial guidance in clinical decision-making.
EXPLORE THE SERIES
For additional COVID-19 resources and discussion forums, visit SITC’s COVID-19 Resources page.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com